Covid 19. Pneumonia due to SARS-associated coronavirus
Conditions
Interventions
Intervention 1: Intervention group: The group receiving 2 drug capsules In addition to standard treatments ( each capsule containing 150 mg Bromelain, 300 mg Curcumin and 50 mg Epigallocatechin ) dail
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: New 2019 Corona-virus infection (COVID-19) confirmed by rt-PCR test referred to an outpatient clinic Aged over 18 years
Exclusion criteria
Exclusion criteria: severe infection needing hospitalization according to the diagnosis of infectious disease specialist History of allergies to green tea, pineapple, latex and turmeric history of peptic ulcer in the last 6 months active bleeding (except for menstrual period ) hepatic or renal failure coagulopathies autoimmune disease pregnancy cholelithiasis administration of anti platelet or anticoagulant agents (except aspirin)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oxygen saturation. Timepoint: Up to two weeks after intervention. Method of measurement: Pulse oximetery.;Body temperature. Timepoint: Up to two weeks after intervention. Method of measurement: Thermometer.;Cough severity. Timepoint: Up to two weeks after intervention. Method of measurement: Clinical manifestations of the patient with a score of 1 to 10 depending on the cough severity.;Myalgia. Timepoint: Up to two weeks after intervention. Method of measurement: Phone call, or visit by person in cases of symptom aggravation.;Gastrointestinal symptoms. Timepoint: Up to two weeks after intervention. Method of measurement: Phone call, or visit by person in cases of symptom aggravation.;Fatigue. Timepoint: Up to two weeks after intervention. Method of measurement: Phone call, or visit by person in cases of symptom aggravation.;Sense of smell. Timepoint: Up to two weeks after intervention. Method of measurement: Phone call, or visit by person in cases of symptom aggravation.;Sense of taste. Timepoint: Up to two weeks after intervention. Method of measurement: Phone call, or visit by person in cases of symptom aggravation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality. Timepoint: Up to one month after intervention. Method of measurement: Phone call, and clinical follow up.;Hospitalization. Timepoint: Up to one month after intervention. Method of measurement: Phone call, and clinical follow up.;Lung involvement. Timepoint: Up to two weeks after intervention. Method of measurement: Phone call, and clinical follow up. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahsa Behnemoon
Oroumia University of Medical Sciences
Outcome results
None listed